Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Nat Commun ; 6: 10216, 2015 Dec 16.
Artículo en Inglés | MEDLINE | ID: mdl-26671725

RESUMEN

Neurofibrillary tangles, composed of hyperphosphorylated tau fibrils, are a pathological hallmark of Alzheimer's disease; the neurofibrillary tangle load correlates strongly with clinical progression of the disease. A growing body of evidence indicates that tau oligomer formation precedes the appearance of neurofibrillary tangles and contributes to neuronal loss. Here we show that tau oligomer formation can be inhibited by compounds whose chemical backbone includes 1,2-dihydroxybenzene. Specifically, we demonstrate that 1,2-dihydroxybenzene-containing compounds bind to and cap cysteine residues of tau and prevent its aggregation by hindering interactions between tau molecules. Further, we show that orally administered DL-isoproterenol, an adrenergic receptor agonist whose skeleton includes 1,2-dihydroxybenzene and which penetrates the brain, reduces the levels of detergent-insoluble tau, neuronal loss and reverses neurofibrillary tangle-associated brain dysfunction. Thus, compounds that target the cysteine residues of tau may prove useful in halting the progression of Alzheimer's disease and other tauopathies.


Asunto(s)
Agonistas Adrenérgicos beta/farmacología , Enfermedad de Alzheimer/metabolismo , Catecoles/farmacología , Cisteína/efectos de los fármacos , Isoproterenol/farmacología , Ovillos Neurofibrilares/efectos de los fármacos , Neuronas/efectos de los fármacos , Proteínas tau/efectos de los fármacos , Agonistas Adrenérgicos beta/química , Animales , Conducta Animal/efectos de los fármacos , Western Blotting , Encéfalo/efectos de los fármacos , Encéfalo/metabolismo , Catecoles/química , Catecoles/metabolismo , Línea Celular Tumoral , Cisteína/metabolismo , Modelos Animales de Enfermedad , Progresión de la Enfermedad , Evaluación Preclínica de Medicamentos , Isoproterenol/química , Ratones , Ratones Transgénicos , Ovillos Neurofibrilares/metabolismo , Neuronas/patología , Polimerizacion , Proteínas tau/genética , Proteínas tau/metabolismo
2.
J Neurochem ; 109(6): 1648-57, 2009 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-19457098

RESUMEN

The deposition of amyloid beta (Abeta) protein is a consistent pathological hallmark of Alzheimer's disease (AD) brains; therefore, inhibition of Abeta fibril formation and destabilization of pre-formed Abeta fibrils is an attractive therapeutic and preventive strategy in the development of disease-modifying drugs for AD. This study demonstrated that Paeonia suffruticosa, a traditional medicinal herb, not only inhibited fibril formation of both Abeta(1-40) and Abeta(1-42) but it also destabilized pre-formed Abeta fibrils in a concentration-dependent manner. Memory function was examined using the passive-avoidance task followed by measurement of Abeta burden in the brains of Tg2576 transgenic mice. The herb improved long-term memory impairment in the transgenic mice and inhibited the accumulation of Abeta in the brain. Three-dimensional HPLC analysis revealed that a water extract of the herb contained several different chemical compounds including 1,2,3,4,6-penta-O-galloyl-beta-D-glucopyranose (PGG). No obvious adverse/toxic were found following treatment with PGG. As was observed with Paeonia suffruticosa, PGG alone inhibited Abeta fibril formation and destabilized pre-formed Abeta fibrils in vitro and in vivo. Our results suggest that both Paeonia suffruticosa and its active constituent PGG have strong inhibitory effects on formation of Abeta fibrils in vitro and in vivo. PGG is likely to be a safe and promising lead compound in the development of disease-modifying drugs to prevent and/or cure AD.


Asunto(s)
Enfermedad de Alzheimer/metabolismo , Péptidos beta-Amiloides/metabolismo , Taninos Hidrolizables/farmacología , Memoria/efectos de los fármacos , Paeonia/química , Extractos Vegetales/farmacología , Enfermedad de Alzheimer/tratamiento farmacológico , Enfermedad de Alzheimer/fisiopatología , Precursor de Proteína beta-Amiloide/genética , Animales , Reacción de Prevención/efectos de los fármacos , Conducta Animal/efectos de los fármacos , Línea Celular Transformada , Supervivencia Celular/efectos de los fármacos , Cromatografía Líquida de Alta Presión/métodos , Modelos Animales de Enfermedad , Ensayo de Inmunoadsorción Enzimática , Ratones , Ratones Transgénicos , Modelos Moleculares , Fragmentos de Péptidos/metabolismo , Fitoterapia/métodos , Factores de Tiempo
3.
J Neurosci Res ; 84(2): 427-33, 2006 Aug 01.
Artículo en Inglés | MEDLINE | ID: mdl-16676329

RESUMEN

Because the deposition of beta-amyloid protein (Abeta) is a consistent pathological hallmark of Alzheimer's disease (AD) brains, inhibition of Abeta generation, prevention of Abeta fibril formation, or destabilization of preformed Abeta fibrils would be attractive therapeutic strategies for the treatment of AD. We examined the effects of several medicinal herbs used in traditional Chinese medical formulae on the formation and destabilization of Abeta fibrils by using the thioflavin T binding assay, atomic force microscopic imaging, and electrophoresis. Our study demonstrates that several of these herbs have potent inhibitory effects on fibril formation of both Abeta(1-40) and Abeta(1-42) in concentration-dependent manners; in particular, Uncaria rhynchophylla inhibited Abeta aggregation most intensively. Significant destabilization of preformed Abeta(1-40) and Abeta(1-42) fibrils was also induced by Uncaria rhynchophylla as well as some other herb extracts. Three-dimensional HPLC analysis indicated that the water extract of this herb contains several different chemical compounds, including oxindole and indol alkaloids, which have been regarded as neuroprotective. Our results suggest that Uncaria rhynchophylla has remarkably inhibitory effects on the regulation of Abeta fibrils, and we conclude that this medicinal herb could have the potency to be a novel therapeutic agent to prevent and/or cure AD.


Asunto(s)
Péptidos beta-Amiloides/química , Péptidos beta-Amiloides/efectos de los fármacos , Enfermedad de Alzheimer/fisiopatología , Benzotiazoles , Cromatografía Líquida de Alta Presión , Relación Dosis-Respuesta a Droga , Medicamentos Herbarios Chinos , Colorantes Fluorescentes , Microscopía de Fuerza Atómica , Tiazoles , Uncaria
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA